乙二醇-聚(咪唑丙基-天冬酰胺)-聚丙氨酸三嵌段共聚物的合成及其pH-响应性药物控制释放性能的研究

聚天冬氨酸及其衍生物是一种具有良好生物相容性和可生物降解性的高分子材料, 被广泛应用于生物医药领域. 本研究通过大分子引发剂ω-胺基-α-甲氧基聚乙二醇引发N-羧基-α-氨基环内酸酐开环聚合和N-(3-氨丙基)咪唑侧基改性, 制备了一种侧链含有咪唑丙基的聚乙二醇-聚(咪唑丙基-天冬酰胺)-聚丙氨酸三嵌段共聚物. 在水溶液中, 此聚合物可自组装形成一种核-壳-冠型的三层共聚物胶束, 其中疏水性的聚丙氨酸链段自聚集形成胶束的核, 聚(咪唑丙基-天冬酰胺)链段形成具有pH-响应性的壳层, 用于包埋和释放药物, 外围的聚乙二醇链段可以提供一个稳定的水合冠层, 延长药物的体内循环时间. 利用咪唑环与游离阿霉素之间的π-π相互作用和疏水相互作用可以在自组装的过程中将阿霉素包埋到胶束内. 研究发现, 载药胶束随环境pH 值的降低药物的释放速率显著增加. 这主要是由于咪唑环在酸性条件下的质子化导致链段亲疏水性质发生明显变化.     

具有pH-响应性的聚天冬氨酸类载药胶束的制备和释放能力研究

通过大分子引发剂ω-氨基-α-甲氧基聚乙二醇引发N-羧基-α-氨基环内酸酐开环聚合和水合肼侧基改性,制备了一系列聚乙二醇-聚氨基酸类三嵌段共聚物.其中聚氨基酸链段包括具有酰肼基的聚天冬氨酸衍生物(PAHy),以及疏水性的聚丙氨酸链段.引入具有pH响应性的腙键键合阿霉素,利用键合阿霉素与游离阿霉素之间的π-π叠合作用,在聚合物自组装形成胶束过程中通过化学键合+物理包埋的方式充分负载药物.该胶束以聚丙氨酸链段为核心,以PEG链段为冠层,以PAHy链段为包裹药物的壳层.载药胶束的粒径在170 nm左右.研究不同pH值条件下载药胶束的药物释放能力,随环境pH值的降低药物的释放速率显著增加.     

聚谷氨酸基双重响应性纳米胶束的制备及药物控释性能

首先制备端氨基聚(N-异丙基丙烯酰胺-co-聚乙二醇)大分子引发剂,再通过端氨基引发L-谷氨酸-γ-苄酯-N-羧酸酐开环聚合,制备了聚(N-异丙基丙烯酰胺-co-聚乙二醇)与聚(L-谷氨酸-γ-苄酯)的嵌段共聚物,将其中的γ-苄酯基团转化为酰肼基团后与阿霉素(DOX)共价结合,最后在水溶液中自组装成纳米胶束,制备了温度和pH值双重响应性纳米胶束。胶束外层由亲水性聚(N-异丙基丙烯酰胺-co-聚乙二醇)组成,具有温敏性,低临界溶液温度为38℃;胶束内层由聚(L-谷氨酸-γ-酰肼-阿霉素)组成。该胶束对于药物的释放具有温度和pH双重敏感性。     

聚L-丙氨酸-聚乙二醇嵌段共聚物纳米胶束的研究

分别以氨基聚乙二醇和氨基聚乙二醇单甲醚为大分子引发剂,采用开环聚合的方法合成了两亲性聚L-丙氨酸-聚乙二醇(PAE)和聚L-丙氨酸-聚乙二醇单甲醚(PAME)两种嵌段共聚物,其结构经1H NMR,IR,DSC,GPC等表征;利用园二色技术研究了其在水溶液中的二级结构,用芘荧光探针技术研究了其胶束的形成及其临界胶束浓度(CMC),利用透射电镜研究了胶束的形态。结果表明,在水溶液中共聚物链以α-螺旋构象形式存在,在一定条件下嵌段共聚物PAE-1,PAE-2,PAME-1和PAME-2能够形成球形的稳定胶束,PAE-1形成胶束的CMC为3.36×10-5mol.L-1,CMC值受嵌段类型和共聚物中聚L-丙氨酸链段含量的影响。     

多响应性聚肽共混胶束的药物控释性能

合成了聚(L-谷氨酸)-b-聚氧化丙烯-b-聚(L-谷氨酸)(PLGA-b-PPO-b-PLGA)三嵌段聚肽共聚物.通过透射电镜、激光光散射与核磁共振等方法研究了其与聚乙二醇-6-聚氧化丙烯(PEG-b-PPO)两嵌段共聚物共混体系的自组装行为,使用紫外分光光度计探讨了负载阿霉素的共混聚集体在不同环境下的释药行为.结果表明:该体系形成了以PPO为内核,PLGA和PEG为壳的共混胶束,该共混胶束的释药行为不仅具有pH和温度的响应性,并且对共混胶束的组分具有依赖性.     

聚L-丙氨酸-聚乙二醇嵌段共聚物的胶束化行为研究

以氨基聚乙二醇单甲醚(MPEG-NH₂)为大分子引发剂, 采用开环聚合方法合成了聚L-丙氨酸-聚乙二醇嵌段共聚物(PAME), 并对其结构进行了表征; 用圆二色谱(CD)研究了嵌段共聚物在水溶液中的二级结构, 用芘荧光探针技术研究了共聚物胶束的形成及其临界胶束浓度(CMC), 利用动态光散射(DLS)和透射电镜(TEM)研究了胶束的粒径分布和形态. 结果表明, 在水溶液中共聚物链以α-螺旋构象形式存在, 在一定条件下嵌段共聚物能够形成球形的稳定胶束, PAME-1形成胶束的CMC为1.99×10^-5 mol/L, CMC值受共聚物中聚L-丙氨酸(PLA)链段含量的影响.     

温度/pH响应性MPEG-b-PCL/PNVCL-b-PCL共聚物复合胶束的制备及载药性质

以基于亚胺键的嵌段共聚物为构筑单元的温度/pH响应性共聚物复合胶束(CMs), 由于具有亚胺键和核-壳-冠结构, 表现出较高的灵敏度和稳定性. 以聚乙二醇单甲醚(MPEG)、 N-乙烯基己内酰胺(NVCL)和ε-己内酯(ε-CL)为原料, 分别制备了端醛基聚乙二醇单甲醚(MPEG-CHO)、 端醛基聚N-乙烯基己内酰胺(PNVCL-CHO)和端氨基聚己内酯(H₂N-PCL), 利用希夫碱反应, 进一步制备了基于亚胺键的聚乙二醇单甲醚-b-聚己内酯(MPEG-b-PCL)和聚N-乙烯基己内酰胺-b-聚己内酯(PNVCL-b-PCL)嵌段共聚物, 对共聚物结构进行了确认. 以MPEG-b-PCL和PNVCL-b-PCL为构筑单元, 制备了共聚物复合胶束, 研究了复合胶束对阿霉素的包载、 释放性质和细胞毒性等. 研究结果表明, 室温下MPEG-b-PCL和PNVCL-b-PCL能够在水中自组装形成以PCL为核、 MPEG和PNVCL为混合壳的共聚物复合胶束, 在生理温度下, 温敏性PNVCL链段发生相变塌缩在PCL核表面, 能够防止药物扩散释放, 亲水性MPEG链段形成可控通道. 药物体外释放结果表明, 在弱酸性环境中, 亚胺键能够断裂, 胶束被破坏, 促进药物的释放, 噻唑蓝(MTT)实验表明, 复合胶束的细胞毒性较低.     

AB型聚乙二醇单甲醚-聚(L-丙氨酸)嵌段共聚物自组装过程的核磁共振研究

利用核磁共振方法研究了AB型双嵌段共聚物(MPEG45-b-PA32)在选择性溶剂中的自组装行为及胶束化过程.嵌段共聚物在三氟乙酸中聚氨基酸和聚乙二醇链段均处于自由运动状态,聚丙氨酸链段为无规线团结构.在向该溶液中逐渐加入氘代水的过程中,聚丙氨酸链段又重新聚集形成规整的二级结构.结合1H-NMR和COSY谱分析,结果显示这一自组装过程伴随着聚(L-丙氨酸)链段由无规线团向α-螺旋结构的构象转变,同时嵌段共聚物逐渐形成核-壳型胶束结构.利用透射电镜观察了所形成胶束的形态,嵌段共聚物主要形成粒径150 nm到220 nm的球形胶束.     

聚环氧乙烷-g-聚己内酯两亲性接枝共聚物的合成及药物释放行为

通过环氧丙醇(GL)与环氧乙烷(EO)的阴离子顺序开环聚合制备了水溶性嵌段共聚物PEO-b-PGL, 以PGL嵌段每个重复单元的侧羟基为引发点进一步引发ε-己内酯(CL)的开环聚合, 合成了结构规整的以聚环氧乙烷(PEO)为主链的两亲性接枝共聚物(PEO-b-PGL-g-PCL). 研究了PEO-b-PGL-g-PCL在水相中的自组装行为, 采用稳态荧光探针法测定了胶束的临界胶束浓度(cmc). 以疏水性药物阿霉素(DOX)为模型药物, 研究了两亲性接枝共聚物的化学组成对药物的扩散释放以及降解释放行为的影响.     

基于聚氨基酸的线型-树状聚两性电解质的合成及pH响应性研究

采用开环聚合、发散法以及"点击化学法"合成了线型-树状聚两性电解质.首先通过γ-苄基-L-谷氨酸酯羧酸酐(BLG-NCA)的开环聚合及发散合成法分别合成了叠氮端基聚(γ-苄基-L-谷氨酸酯)(PBLG-N3)及以炔基为内核的带有4个伯氨端基的第2.0代聚酰胺-胺(PAMAM-D2),再将二者通过"点击反应"制备的线型-树状嵌段共聚物PBLG-b-D2作为大分子引发剂,利用其末端氨基引发ε-苄氧羰基-L-赖氨酸羧酸酐(ZLL-NCA)的开环聚合,获得线型-树状嵌段共聚物PBLG-b-D2-(PZLL)4,再经酸解脱除PBLG上的苄基及PZLL上的苄氧羰基,获得目标产物聚(L-谷氨酸)-b-聚[酰胺-胺-聚(L-赖氨酸)](PLGA50-b-D2-(PLL9)4)线型-树状聚两性电解质.通过核磁(1H-NMR)、傅里叶变换红外光谱(FTIR)和凝胶渗透色谱(GPC)表征了聚合物分子结构、分子量及其分布;通过电导滴定法、1H-NMR、zeta电位、激光光散射(LLS)、扫描电子显微镜(SEM)及圆二色谱(CD)等方法研究了PLGA50-b-D2-(PLL9)4对溶液pH值响应性.结果表明随溶液pH由酸性转变为碱性,PLGA50-b-D2-(PLL9)4显示出了多重胶束化行为,同时不对称的线型-树状分子拓扑结构影响了聚集体的形貌,在酸性pH值下形成以PLGA为核的球形胶束,而在碱性pH值下形成以PLL为核的棒状胶束,并分别伴随着PLGA及PLL链段构象从无规线团向螺旋构象的转变.     

Self-assembly behavior of pH- and thermosensitive amphiphilic triblock copolymers in solution: experimental studies and self-consistent field theory simulations

We investigated, both experimentally and theoretically, the self-assembly behaviors of pH- and thermosensitive poly(L-glutamic acid)- b-poly(propylene oxide)-b-poly(L-glutamic acid) (PLGA-b-PPO-b-PLGA) triblock copolymers in aqueous solution by means of transmission electron microscopy (TEM), scanning electron microscopy (SEM), dynamic light scattering (DLS), circular dichroism (CD), and self-consistent field theory (SCFT) simulations. Vesicles were observed when the hydrophilic PLGA block length is shorter or the pH value of solution is lower. The vesicles were found to transform to spherical micelles when the PLGA block length increases or its conformation changes from helix to coil with increasing the pH value. In addition, increasing temperature gives rise to a decrease in the size of aggregates, which is related to the dehydration of the PPO segments at higher temperatures. The SCFT simulation results show that the vesicles transform to the spherical micelles with increasing the fraction or statistical length of A block in model ABA triblock copolymer, which corresponds to the increase in the PLGA length or its conformation change from helix to coil in experiments, respectively. The SCFT calculations also provide chain distribution information in the aggregates. On the basis of both experimental and SCFT results, the mechanism of the structure change of the PLGA- b-PPO- b-PLGA aggregates was proposed.     

Development of biocompatible electrostatic-repulsive microparticles for local tumor treatment

In this study, we reported pH-responsive microparticles consisting of poly(D,L-lactide-co-glycolide) (PLGA), aminated hyaluronic acid (aHA) conjugated with 2,3-dimethylmaleic anhydride (DMA, as a pH-responsive cleavable molecule) (aHA-DMA), and doxorubicin (DOX, as an antitumor drug) for local tumor treatment. The DOX-loaded microparticles, denoted as PLGA(aHA-DMA)/DOX MPs, were fabricated using the W₁/O/W₂ multi-emulsification method. These PLGA(aHA-DMA)/DOX MPs (~10 μm in diameter) accelerated the rate of DOX release at pH 6.8 due to the acidic pH-responsive cleavage of the DMA moieties followed by electrostatic-repulsion between aHA and DOX. This event caused the structural destabilization and collapse of the MPs, leading to the rapid release of DOX. Consequently, the PLGA(aHA-DMA)/DOX MPs resulted in significant inhibition of tumor growth, demonstrating their ability for acidic tumor-specific treatment.     

以磁纳米粒为核的pH敏感型聚谷氨酸树状分子药物载体

报道了一种新的肽类树枝状分子改性磁性纳米药物载体.以天然氨基酸L-谷氨酸为原料,通过收敛法合成了聚(L-谷氨酸)树状分子,将多巴胺配体键合到聚(L-谷氨酸)树状分子上,用核磁(1H-NMR)、质谱(MS)对合成出的树状分子配体进行了表征,然后通过配体交换对四氧化三铁磁纳米粒表面进行多功能化.以阿霉素为模型药物通过pH敏...     

Fabrication of polymeric micelles with core–shell–corona structure for applications in controlled drug release

Thermo-responsive polymeric micelles of poly (ethylene glycol)-b-poly(2-hydroxyethyl methacrylate-g-lactide)-b-poly(N-isopropylacrylamide) (PEG-P(HEMA-PLA)-PNIPAM) with core–shell–corona structure were fabricated for applications in controlled drug release. The graft copolymer of PEG-P(HEMA-PLA)-PNIPAM was self-assembled into core–shell micelles with a densely PLA core and mixed PEG/PNIPAM shells at 25 °C in aqueous media. By increasing the temperature above the lower critical solution temperature of PNIPAM, these core–shell micelles could be converted into core–shell–corona micelles because of the collapse of PNIPAM block on the PLA core as the inner shell and the soluble PEG block stretching outside as the outer corona. Anticancer drug doxorubicin (DOX) was loaded in the polymeric micelles as a model drug. Compared with polymeric micelles formed by liner PEG-b-PLA-b-PNIPAM triblock copolymer, these polymeric micelles exhibited higher loading capacity, and release of DOX from the polymeric micelles with core–shell–corona structure was well-controlled.     

Synthesis,self-assembly,and pH-responsive drug release of PHMEMA-PEG-PHMEMA ABA triblock copolymers

Abstract

A series of tertiary amine containing PHMEMA-PEG-PHMEMA ABA triblock copolymers were synthesized by atom transfer radical polymerization (ATRP) using bromine-capped poly(ethylene glycol) (Br-PEG-Br) and 2-(hexamethyleneimino)ethyl methacrylate (HMEMA) as macro-initiator and monomers, respectively. The chemical structures and molecular weights of triblock copolymers were characterized by ¹H NMR and gel permeation chromatography (GPC). The self-assembly behaviors of copolymers in different pH conditions were studied by dynamic light scattering (DLS) and transmission electron microscopy (TEM). Triblock copolymers self-assembled into micelles in water (pH 7.4) and the micelles disassembled at acidic pH (pH 5.0). Anticancer drug doxorubicin (DOX) was used as a drug model and physically encapsulated into polymeric micelles. The drug release of DOX-loaded polymeric micelles was pH-responsive; the drug-loaded micelles that had higher contents of tertiary amine in polymer pendant groups showed faster release speed. In addition, the drug-loaded micelles showed excellent inhibition efficacy against HeLa cells in vitro.     

Self‐assembly of thermo‐ and pH‐responsive poly(acrylic acid)‐b‐poly(N‐isopropylacrylamide) micelles for drug delivery

Self‐assembled thermo‐ and pH‐responsive poly(acrylic acid)‐b‐poly(N‐isopropylacrylamide) (PAA‐b‐PNIPAM) micelles for entrapment and release of doxorubicin (DOX) was described. Block copolymer PAA‐b‐PNIPAM associated into core‐shell micelles in aqueous solution with collapsed PNIPAM block or protonated PAA block as the core on changing temperature or pH. Complexation of DOX with PAA‐b‐PNIPAM triggered by the electrostatic interaction and release of DOX from the complexes due to the changing of pH or temperature were studied. Complex micelles incorporated with DOX exhibited pH‐responsive and thermoresponsive drug release profile. The release of DOX from micelles was suppressed at pH 7.2 and accelerated at pH 4.0 due to the protonation of carboxyl groups. Furthermore, the cumulative release of DOX from complex micelles was enhanced around LCST ascribed to the structure deformation of the micelles. © 2008 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 46: 5028–5035, 2008     

Poly(ethylene oxide)-poly(styrene oxide)-poly(ethylene oxide) copolymers: Micellization, drug solubilization, and gelling features

Two new poly(ethylene oxide)-poly(styrene oxide) triblock copolymers (PEO-PSO-PEO) with optimized block lengths selected on the basis of previous studies were synthesized with the aim of achieving a maximal solubilization ability and a suitable sustained release, while keeping very low material expense and excellent aqueous copolymer solubility. The self-assembling and gelling properties of these copolymers were characterized by means of light scattering, fluorescence spectroscopy, transmission electron microscopy, and rheometry. Both copolymers formed spherical micelles (12-14 nm) at very low concentrations. At larger concentration (>25 wt%), copolymer solutions showed a rich phase behavior, with the appearance of two types of rheologically active (more viscous) fluids and of physical gels depending on solution temperature and concentration. The copolymer behaved notably different despite their relatively similar block lengths. The ability of the polymeric micellar solutions to solubilize the antifungal drug griseofulvin was evaluated and compared to that reported for other structurally-related block copolymers. Drug solubilization values up to 55 mg g⁻¹ were achieved, which are greater than those obtained by previously analyzed poly(ethylene oxide)-poly(styrene oxide), poly(ethylene oxide)-poly(butylene oxide), and poly(ethylene oxide)-poly(propylene oxide) block copolymers. The results indicate that the selected SO/EO ratio and copolymer block lengths were optimal for simultaneously achieving low critical micelle concentrations (cmc) values and large drug encapsulation ability. The amount of drug released from the polymeric micelles was larger at pH 7.4 than at acidic conditions, although still sustained over 1 day.